QVT: Funding, Team & Investors | Startup Intros

Loading organizations...

QVT: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 18, 2025	Syremis Therapeutics	$165.0M Series A	Uri Oren, Reid Huber	Google Ventures, Raymond Sanchez, M.D., Pictet Alternative Advisors
May 13, 2024	Active Surfaces	$5.6M Pre-Seed	Safar Partners	Lendlease, New Climate Ventures, Sabanci Climate Ventures, SeaX Ventures, Type One Ventures, Umami Capital
May 16, 2022	Kriya Therapeutics	$270.0M Series C	Jim Momtazee	Bluebird Ventures, CAM Capital, Dexcel Pharma, Foresite Capital, JDRF T1D Fund, Lightswitch Capital, Narya Capital, Transhuman Capital
Jul 14, 2021	Kriya Therapeutics	$100.0M Series B	Jim Momtazee	Alumni Ventures, Amplo, Bluebird Ventures, CAM Capital, Dexcel Pharma, Foresite Capital, Hongkou, JDRF, Narya Capital, Transhuman Capital, Woodline Partners
Sep 1, 2015	AveXis	$65.0M Series D	Taymour Tamaddon	Atlas Venture, Deerfield Management, Hatteras Venture Partners, Omega Funds, RA Capital, Roche Venture Fund, Jonathan Root, Adage Capital Management, Boxer Capital, Foresite Capital, Janus Henderson Investors, RA Capital Management, Roche, Rock Springs Capital, RTW Investments, Venrock
May 1, 2015	REGENXBIO	$71.0M Series D	Venrock, Vivo Capital, Brookside Capital	ARCH Venture Partners, Canaan Partners, Cormorant Asset Management, Deerfield Management, Foresite Capital, F-Prime Capital, Janus Henderson Investors, Jennison Associates, Perceptive Advisors, RTW Investments, Sectoral Asset Management, Tourbillon Global Ventures